Home / United Kingdom / Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC No short position is open on this share today.
Follow
0.00% of the capital sold short
0 disclosing funds
266 disclosures on record
Evolution of the disclosed total 0% 1%
Oct 2025 Jan 2026 Apr 2026 Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up. Over the whole history, the total peaked at 6.51% on July 19, 2017. The shaded band matches the twelve months of the first chart. November 1, 2012 today
Open positions No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Follow by RSS
Get the moves on Hikma Pharmaceuticals PLC by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures 266 disclosures on record for this share. Date Fund % of capital End of publication June 22, 2017 Pointstate Capital LP 0.52% June 19, 2017 AQR Capital Management, LLC 1.60% June 16, 2017 Millennium International Management LP 0.54% June 16, 2017 Marshall Wace LLP 0.47% June 15, 2017 Millennium International Management LP 0.71% June 9, 2017 AQR Capital Management, LLC 1.50% June 9, 2017 Millennium International Management LP 0.60% June 1, 2017 AQR Capital Management, LLC 1.41% May 22, 2017 Marshall Wace LLP 0.50% May 19, 2017 Millennium International Management LP 0.50% May 19, 2017 Pointstate Capital LP 0.46% May 17, 2017 Pointstate Capital LP 0.56% May 15, 2017 AKO Capital LLP FOR AKO Master Fund Limited 0.99% May 12, 2017 Pointstate Capital LP 0.64% April 28, 2017 Pointstate Capital LP 0.73% April 26, 2017 Pointstate Capital LP 0.67% April 25, 2017 Pointstate Capital LP 0.77% April 24, 2017 AKO Capital LLP FOR AKO Master Fund Limited 1.11% April 20, 2017 Pointstate Capital LP 0.84% April 19, 2017 AQR Capital Management, LLC 1.30% April 4, 2017 AQR Capital Management, LLC 1.28% April 4, 2017 AKO Capital LLP FOR AKO Master Fund Limited 0.90% April 3, 2017 AQR Capital Management, LLC 1.30% March 31, 2017 AQR Capital Management, LLC 1.29% March 31, 2017 Marshall Wace LLP 0.48% March 30, 2017 AQR Capital Management, LLC 1.30% March 29, 2017 AKO Capital LLP FOR AKO Master Fund Limited 0.84% March 28, 2017 Marshall Wace LLP 0.56% March 27, 2017 AQR Capital Management, LLC 1.29% March 24, 2017 Pointstate Capital LP 0.74% March 22, 2017 Pointstate Capital LP 0.87% March 21, 2017 AQR Capital Management, LLC 1.30% March 20, 2017 Marshall Wace LLP 0.61% March 16, 2017 AQR Capital Management, LLC 1.29% March 16, 2017 Coatue Management, L.L.C. 0.90% March 15, 2017 AQR Capital Management, LLC 1.30% March 15, 2017 Pointstate Capital LP 0.91% March 15, 2017 Coatue Management, L.L.C. 0.88% March 15, 2017 Healthcor Management, L.P. 0.32% March 9, 2017 Pointstate Capital LP 0.83% March 3, 2017 Pointstate Capital LP 0.70% March 3, 2017 Marshall Wace LLP 0.58% March 1, 2017 Pointstate Capital LP 0.62% February 27, 2017 Pointstate Capital LP 0.59% February 24, 2017 Pointstate Capital LP 0.63% February 23, 2017 Healthcor Management, L.P. 0.54% February 17, 2017 Marshall Wace LLP 0.68% February 14, 2017 AQR Capital Management, LLC 1.20% February 8, 2017 Marshall Wace LLP 0.79% February 8, 2017 AKO Capital LLP FOR AKO Master Fund Limited 0.70%
Download 266 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Page 4 of 6
Other companies sold short in the United Kingdom Cite this page The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Hikma Pharmaceuticals PLC, source FCA, data as at September 19, 2019, https://www.quivad.com/action/hikma-pharmaceuticals-plc?page=4